Medical/Pharmaceuticals
AtomVie Global Radiopharma Celebrates the Grand Opening of its New State-of-the-Art Radiopharmaceutical Manufacturing Facility in Hamilton, Ontario
HAMILTON, ON, Sept. 5, 2026 /PRNewswire/ - AtomVie Global Radiopharma (AtomVie), a leading global Contract Development and Manufacturing Organization (CDMO) in the radiopharmaceutical industry, today celebrated the Grand Opening of its new purpose-built, state-of-the-art manufacturing facility at...
2026-09-05 00:29
2934
HoneyNaps Develops Next-Generation Wireless PSG system Using Four Skin Patches
* Patch-based wireless sensors and AI-powered analysis combine to improve patient comfort and clinical efficiency in polysomnography * New platform reduces more than 24 wired sensors to four compact patches, with potential applications in hospitals, home sleep testing and remote monitoring ...
2026-09-04 19:00
2158
DIMERIX SECURES A$34 MILLION NON-DILUTIVE FACILITY TO FUND KEY CLINICAL MILESTONES
* Dimerix successfully enters into non-dilutive facility agreements to access A$34 million[1] with a syndicate of Australian and U.S. independent lenders, including the previously announced initial facility of A$10 million[2] * Facility terms for all Lenders substantially consistent with the p...
2026-09-04 19:00
1538
Acepodia Announces FDA Clearance of IND Application for ACE723, a Novel Dual-Payload Antibody-Drug Conjugate
FDA clearance enables initiation of a Phase 1 clinical trial and advances the first AD2C-generated candidate into clinical development ALAMEDA, Calif. and TAIPEI, Sept. 4, 2026 /PRNewswire/ -- Acepodia (6976: TT), a clinical-stage biotechnology company developing next-generation cell therapies a...
2026-09-04 19:00
1606
DIMERIX SECURES A$34 MILLION NON-DILUTIVE FACILITY TO FUND KEY CLINICAL MILESTONES
* Dimerix successfully enters into non-dilutive facility agreements to access A$34 million[1] with a syndicate of Australian and U.S. independent lenders, including the previously announced initial facility of A$10 million[2] * Facility terms for all Lenders substantially consistent with the p...
2026-09-04 11:00
1842
Carestream Healthcare International Enhances DRX‑LC Detector to Level Up Long‑Length Imaging Performance
SHANGHAI, Sept. 4, 2026 /PRNewswire/ -- Carestream Healthcare International is
introducing the latest version of its DRX‑LC Detector, delivering enhanced
imaging performance, efficiency, and quality for long‑length imaging across a
wide range of exams and clinical environments.
2026-09-04 10:00
2174
TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations
Integration brings serialized product verification and traceability directly into medication receiving workflows, intended to enable more efficient pharmacy operations without separate compliance processes. BOSTON, Sept. 3, 2026 /PRNewswire/ -- TraceLink, the world's largest Agentic Business Net...
2026-09-03 22:00
1899
Neurophet Appoints Leading U.S. Dementia Imaging Expert Dr. Ana M. Franceschi as Scientific Advisor
* Dr. Franceschi currently serves as Director of Dementia Imaging and Director of Molecular Neuroimaging at Northwell Health, where she has led advances in brain MRI and PET imaging technologies * Neurophet aims to strengthen the clinical evidence for its key products and accelerate its expan...
2026-09-03 21:00
2225
NUHS AND ITS INSTITUTIONS SECURE GOLD AND MULTIPLE AWARDS AT HOSPITAL MANAGEMENT ASIA AWARDS 2026
Six projects from across the healthcare cluster honoured for community impact, healthcare technology, sustainability and talent development SINGAPORE, Sept. 3, 2026 /PRNewswire/ -- To nurture a future-ready healthcare workforce, the National University Hospital (NUH) developed a scalable and sus...
2026-09-03 21:00
1817
Pulnovo Medical Announces Results of the PADN-HF-PH Trial at ESC Congress 2026, Simultaneously Published in The New England Journal of Medicine (NEJM)
Clinical outcomes from 264 PH-LHD patients demonstrate a 51% reduction in the risk of clinical worsening, a 35.5% decrease in recurrent clinical events, and sustained concurrent improvements in functional capacity, supporting the multi-dimensional therapeutic benefits of thePulmonary Artery Dener...
2026-09-03 19:53
1490
Tucker Medical selects GE HealthCare MRI technology to advance personalized preventive care in Singapore
Collaboration will explore clinical education, knowledge exchange and imaging excellence across Southeast Asia * Tucker Medical has installed a SIGNA™ 1.5T magnetic resonance imaging system at its Novena Specialist Center in Singapore to support its personalized, risk-informed approach to asse...
2026-09-03 16:20
2037
ClinHope Officially Establishes Hong Kong Branch to Strengthen Asia-Pacific Market Presence
TAIPEI, Sept. 3, 2026 /PRNewswire/ -- ClinHope today announced the official establishment of its Hong Kong branch. Following its operations in Taiwan and the United States, this marks another step in expanding into the Asian market and deepening its global service footprint. As the biotech, phar...
2026-09-03 16:09
1396
In Indonesia, stroke care delays accumulate on the way to treatment, new report finds
Indonesian experts call for capability-based referral routing, greater investment in trained stroke teams and broader insurance coverage to close the gap between Western and Eastern Indonesia. JAKARTA, Indonesia, Sept. 3, 2026 /PRNewswire/ -- Structural delays occurring before patients reach tre...
2026-09-03 13:21
1449
Everest Medicines Announces China NMPA Approval of CARDAMYST® for the Conversion of Acute Symptomatic Episodes of Paroxysmal Supraventricular Tachycardia (PSVT) to Sinus Rhythm in Adults
SHANGHAI, Sept. 3, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that China's National Medical Product...
2026-09-03 13:20
1707
Insilico Medicine Included in the HKEX Tech 100 Index, Drawing Attention to Opportunities in AI Value Chain
CAMBRIDGE, Mass., Sept. 2, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", HKEX: 3696), a clinical-stage drug discovery company powered by generative artificial intelligence (AI), announced that it will be included in the HKEX Tech 100 Index, following the methodology enhancements to broaden ...
2026-09-03 08:30
1875
The Galien Foundation Announces the Nominees for the Inaugural 2026 Prix Galien Korea Awards
Historic First Edition Launches in Partnership with MK Media (Maekyung), Yozma Group Korea, the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA), and KoreaBIO at the World Knowledge Forum in Seoul SEOUL, South Korea, Sept. 3, 2026 /PRNewswire/ -- The Galien Foundation, the p...
2026-09-03 08:00
1435
Ivonescimab Meets Overall Survival Key Secondary Endpoint in Interim Analysis of Phase III HARMONi-2 Study, Demonstrating Statistically Significant and Clinically Meaningful Benefit Versus Pembrolizumab in First-Line PD-L1-Positive NSCLC
HONG KONG, Sept. 2, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that a pre-specified interim analysis of overall survival (OS) in the HARMONi-2 (AK112-303) trial, as assessed by the Independent Data Monitoring Committee (IDMC), met the key secondary endpo...
2026-09-03 05:00
1856
EpiVax Launches AI-Enhanced Models for Immunogenicity Prediction
PROVIDENCE, R.I., Sept. 3, 2026 /PRNewswire/ -- EpiVax, Inc. is pleased to
announce the release of AI-enabled enhancements toISPRI™
2026-09-02 23:19
1435
Alteogen Enters Option and License Agreement with Novartis for Development and Commercialization of Hybrozyme™-Enabled Subcutaneous Products
* Novartis obtains rights to develop and commercialize subcutaneous formulations for multiple products utilizing ALT-B4 * Alteogen's fourth licensing agreement signed this year further accelerating the expansion of the Hybrozyme™ platform DAEJEON, South Korea, Sept. 2, 2026 /PRNewswire/ -- Al...
2026-09-02 19:00
2470
NovaGo Therapeutics Closes USD 30 Million Series B Financing to Advance Proof-of-Concept Study in Acute Spinal Cord Injury
Round led by Neurimmune and Pureos, with participation from existing and new investors; complemented by non-dilutive funding from the Swiss Paraplegic Foundation and Wings for Life - Spinal Cord Research Foundation. SCHLIEREN, Switzerland, Sept. 2, 2026 /PRNewswire/ -- NovaGo Therapeutics AG, a ...
2026-09-02 18:00
2179
Week's Top Stories
Most Reposted
Hong Leong Bank Unveils HLB opus Extended Exclusively by Private Invitation
[Picked up by 317 media titles]
2026-09-03 23:53
Agoda Named Official Travel Partner of Eurovision's Inaugural Asian Edition
[Picked up by 312 media titles]
2026-09-02 12:17
Visa Launches Enhanced A2A Protect Innovations to Help Financial Institutions Stop Fraud Before Money Leaves Accounts
[Picked up by 311 media titles]
2026-09-02 08:30Klook Takes Creator Commerce Beyond Influence With Kreator Shops
[Picked up by 307 media titles]
2026-09-01 11:00
DayOne and TNB Explore Up To 1.5 GW of On-Site Power Generation to Advance Malaysia's Energy Resilience and Digital Economy
[Picked up by 292 media titles]
2026-09-01 17:36Most Read
Klook Takes Creator Commerce Beyond Influence With Kreator Shops
2026-09-01 11:00
6397
Agoda Named Official Travel Partner of Eurovision's Inaugural Asian Edition
2026-09-02 12:17
5752
